YOLK SAC TUMOR
Clinical trials for YOLK SAC TUMOR explained in plain language.
Never miss a new study
Get alerted when new YOLK SAC TUMOR trials appear
Sign up with your email to follow new studies for YOLK SAC TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on childhood cancers in early trial
Disease control OngoingThis study tests a new treatment called AGAR T cells for children whose solid tumors (like liver cancer or Wilms tumor) have returned or not responded to standard care. The treatment involves taking a patient's own immune cells, adding genes to help them recognize and attack tumo…
Matched conditions: YOLK SAC TUMOR
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 17, 2026 04:35 UTC
-
Engineered t cells take on Hard-to-Treat cancers
Disease control OngoingThis early-stage trial tests a new treatment called CATCH T cells for people with certain solid tumors that have come back or not responded to standard care. The treatment involves taking a patient's own immune cells, adding new genes to help them recognize and attack cancer cell…
Matched conditions: YOLK SAC TUMOR
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 13, 2026 16:00 UTC